🇪🇸 Spain Country × Condition
multiple myeloma Clinical Trials in Spain
Active clinical trials for multiple myeloma with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇪🇸 Spain
Active Trials in Spain (2)
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Enrollment
149 pts
Country
🇪🇸 Spain
Regeneron Pharmaceuticals
View Trial → NCT05372354 Phase 1, Phase 2
Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Enrollment
260 pts
Country
🇪🇸 Spain
Bristol-Myers Squibb
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Spain?
There are currently 2 active clinical trials for multiple myeloma with sites in Spain, of which 2 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Spain?
To join a multiple myeloma clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Spain?
Active multiple myeloma trials in Spain span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology